OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant vaccines in 2022: a perspective from the cell factory
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Progress and prospects on vaccine development against monkeypox infection
Mohamed J. Saadh, Tahmineh Ghadimkhani, Narges Soltani, et al.
Microbial Pathogenesis (2023) Vol. 180, pp. 106156-106156
Open Access | Times Cited: 42

Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination
Junaid Nazir, Tasaduq Manzoor, Afnan Saleem, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3

Evolving Paradigms of Recombinant Protein Production in Pharmaceutical Industry: A Rigorous Review
Achuth Jayakrishnan, Wan Rosalina Wan Rosli, Ahmad Rashidi Mohamed Tahir, et al.
Sci (2024) Vol. 6, Iss. 1, pp. 9-9
Open Access | Times Cited: 12

Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7

Green biotherapeutics: overcoming challenges in plant-based expression platforms
R. R. Jadhav, Deepa Khare
Plant Biotechnology Reports (2024) Vol. 18, Iss. 4, pp. 465-486
Closed Access | Times Cited: 6

Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches
Piotr Rzymski, Aliyu Tijani Jibril, Laila Rahmah, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access | Times Cited: 5

Immunogenic evaluation of LptD + LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae
Narjes Noori Goodarzi, Seyed Mahmoud Barzi, Soheila Ajdary, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
In‐Chan Hwang, Valerie Diane Valeriano, Ji Hoon Song, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11

Zinc-Assisted Microscale Granules Made of the SARS-CoV-2 Spike Protein Trigger Neutralizing, Antivirus Antibody Responses
Marianna Teixeira de Pinho Favaro, Patricia Álamo, Nerea Roher, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 3, pp. 954-962
Open Access | Times Cited: 3

Nanoparticle-Based Secretory Granules Induce a Specific and Long-Lasting Immune Response through Prolonged Antigen Release
Laia Bosch-Camós, Carlos Martínez-Torró, Hèctor López‐Laguna, et al.
Nanomaterials (2024) Vol. 14, Iss. 5, pp. 435-435
Open Access | Times Cited: 3

Recombinant Proteins for Assembling as Nano- and Micro-Scale Materials for Drug Delivery: A Host Comparative Overview
José Luís Corchero, Marianna Teixeira de Pinho Favaro, M. Márquez, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1197-1197
Open Access | Times Cited: 7

Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches
Saigha Marriam, Muhammad Sher Afghan, Mazhar Nadeem, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7

Recombinant vaccines: Current updates and future prospects
Vivek Kumar, Anuj A. Verma, Riddhi Singh, et al.
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 8, pp. 338-350
Open Access | Times Cited: 2

Nanoparticle-Based Secretory Granules Induce a Specific and Long-Lasting Immune Response through Prolonged Antigen Release
Laia Bosch-Camós, Carlos Martínez-Torró, Hèctor López‐Laguna, et al.
(2024)
Open Access | Times Cited: 1

Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies
Maysa Santos Barbosa, Beatriz Almeida Sampaio, Joachim Spergser, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 156-156
Open Access | Times Cited: 1

Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Sogand Vahidi, Arefeh Zabeti Touchaei
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography
José Vicente Carratalá, Jan Atienza-Garriga, Hèctor López‐Laguna, et al.
Microbial Cell Factories (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Precise modification of the surface charge of antigen enhances vaccine immunogenicity
Xiaodong Zai, Zhiling Zhang, Chuge Zhou, et al.
The Innovation (2023) Vol. 4, Iss. 4, pp. 100451-100451
Open Access | Times Cited: 3

Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques
Maxim Solomadin, Kairat Tabynov, Nikolai Petrovsky, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3

Mucosal Administration of Lactobacillus casei Surface-Displayed HA1 Induces Protective Immune Responses against Avian Influenza A Virus in Mice
Dung T. Huynh, W. A. Gayan Chathuranga, Kiramage Chathuranga, et al.
Journal of Microbiology and Biotechnology (2023) Vol. 34, Iss. 3, pp. 735-745
Open Access | Times Cited: 3

Biopharmaceutical Production by Recombinant DNA Technology: Future Perspectives
Subramani Parasuraman, Lakshmi Narayanan Dinesh Kumar, Ganeson Thanapakiam, et al.
(2024), pp. 285-303
Closed Access

Leveraging Walnut Somatic Embryos as a Biomanufacturing Platform for Recombinant Proteins and Metabolites
Paulo A. Zaini, Katia Haddad, Noah G. Feinberg, et al.
BioTech (2024) Vol. 13, Iss. 4, pp. 50-50
Open Access

Advances in protein subunit vaccines against H1N1/09 influenza
Yu Zhang, Jingyao Gao, Wenqi Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines
Gregory J. Wilson, L. W. Preston Church, Colleen F. Kelley, et al.
The Journal of Infectious Diseases (2024)
Closed Access

Page 1 - Next Page

Scroll to top